Our Philadelphia Risperdal Injury Lawyers represent people who sustained personal injuries from the dangerous side effects of Risperdal. Risperdal is an anti-psychotic drug manufactured by Johnson & Johnson that is often prescribed to treat:
- autism behavioral problems
- schizophrenia, and
- bipolar disease
Risperdal has been linked to serious injuries in children and adolescents, including:
- Gynecomastia (growth of abnormal breast tissue in male boys and adolescents), and
- excessive weight gain and Diabetes
Risperdal has also been linked to:
- death in elderly users, and
- Tardive Dyskinesia (an uncontrollable movement disorder)
Risperdal Injuries in Children and Adolescents
The U.S. Food and Drug Administration (FDA) initially approved Risperdal in 1994 to treat schizophrenia in adults. The FDA approved Risperdal to treat children and adolescents for autism-related irritability in 2006. In 2007, FDA approval expanded to include treatment of children / adolescents:
- between ages 13 and 17, for schizophrenia, and
- between ages 10 and 17, for bipolar disorder
Even before the FDA approved Risperdal for use by children and adolescents, however, Johnson & Johnson promoted the off-label use of the drug for children’s:
- ADHD (Attention Deficit Hyperactivity Disorder)
- OCD (Obsessive Compulsive Disorder), and
- ODD (Oppositional Defiant Disorder)
As a result, large numbers of children and adolescents sustained serious injuries from Risperdal before FDA approval expanded to treatment of these age groups.
Risperdal and Gynecomastia
Risperdal increases levels of prolactin in a user’s body. Prolactin is a hormone that enables females to produce breast milk. A male boy or adolescent who uses Risperdal can develop excess breast tissue resembling female breasts from this increase in prolactin. In some cases, these abnormal male breasts grow to size 46DD.
Gynecomastia can have devastating effects on a boy or young man. Children afflicted with Gynecomastia suffer bullying and humiliation as well as rejection by their peers. In addition, surgery to repair Gynecomastia can lead to infections, nerve damage, and pain.
Risperdal and Diabetes
Risperdal also leads to excessive weight gain and Diabetes in children and adolescents. A research study published in JAMA Psychiatry in 2013 showed that children and teenagers who take Risperdal are 3 times as likely to develop Diabetes as non-users within their first year of Risperdal treatment.
Risperdal lawsuits filed against Johnson & Johnson by Philadelphia Risperdal Injury Lawyers allege that Johnson & Johnson:
- was aware of the dangerous side effects of Risperdal
- knew of the increased risk of serious injuries from Risperdal side effects
- failed to adequately warn physicians and consumers of these risks, and
- marketed Risperdal for use by children and adolescents without FDA approval